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The crystal structure of the regulatory domain of NMB2055, a putative MetR
regulator from Neisseria meningitidis, is reported at 2.5 A˚ resolution. The
structure revealed that there is a disulfide bond inside the predicted effector-
binding pocket of the regulatory domain. Mutation of the cysteines (Cys103 and
Cys106) that form the disulfide bond to serines resulted in significant changes
to the structure of the effector pocket. Taken together with the high degree
of conservation of these cysteine residues within MetR-related transcription
factors, it is suggested that the Cys103 and Cys106 residues play an important
role in the function of MetR regulators.
1. Introduction
NMB2055 is one of six LysR-type regulators (LTTRs) encoded in the
genome of the human pathogen Neisseria meningitidis. Exclusively
found in prokaryotes, LTTRs regulate the genes of a diverse range
of biological pathways, including oxidative stress and amino-acid
metabolism. A typical LTTR has an approximate molecular weight
of 35 kDa and comprises an N-terminal DNA-binding domain
(DBD; 65 residues) connected via a linker helix (30 residues) to
a C-terminal regulatory domain (200 residues). The regulatory
domain (RD) adopts a fold similar to that of periplasmic binding
proteins. Classically, LTTRs oligomerize to form biological tetramers
which bind to DNA to repress or activate transcription in response to
binding to one or more effectors (Schell, 1993). The crystal structures
of several full-length LTTRs are known, including CbnR, TsaR, ArgP
and AhpB (Muraoka et al., 2003; Monferrer et al., 2010; Zhou et al.,
2010; Taylor et al., 2012), which form either open or closed tetramers,
and two others that have distinct oligomeric states, namely CrgA,
which forms an octamer (Sainsbury et al., 2009), and BenM, which
forms an extended array of connected dimers (Ruangprasert et al.,
2010).
NMB2055 shares 42% amino-acid sequence identity with MetR, a
regulator of methionine biosynthesis in Escherichia coli and
Salmonella typhimurium. The regulatory domains which make up
most of the LysR sequence (Fig. 1c) share 37% sequence identity,
whereas the DNA-binding domains are 47% identical. MetR was first
reported as a trans-acting element required for the activation ofmetE
and metH, which code for homocysteine methylases. These enzymes
catalyse the final stage of methionine biosynthesis, namely the
methylation of homocysteine to form l-methionine (Urbanowski et
al., 1987). The genes for MetE and MetR are located adjacent to each
other in the genomes of both S. typhimurium and E. coli and are
transcribed from divergent overlapping promoters. MetR-dependent
transcription from both metE and metH is modulated by their
substrate, homocysteine. Thus, in the presence of exogeneous
homocysteine MetR stimulates expression of metE and repression of
metH in S. typhimurium and E. coli (Urbanowski & Stauffer, 1989).
Homocysteine has been shown to increase MetR DNA binding to the
S. typhimurium metE promoter region in vitro, suggesting that it may
interact directly with MetR, presumably through the regulatory
domain of the protein (Sperandio et al., 2007). Other genes regulated
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Figure 1
The structure of the NMB2055 regulatory domain shows a conserved disulfide bond in the putative effector site. (a) The NMB2055 regulatory-domain dimer structure solved
to 2.5 A˚ resolution. The secondary-structure elements are labelled for chain A and the side chains of the cysteine residues are shown as sticks. (b) Unbiased initial electron
density calculated by RESOLVE for the disulfide bond between Cys103 and Cys106 contoured at 1. (c) Multiple sequence alignment of MetR homologues and CbnR (PDB
entry 1iz1; Muraoka et al., 2003) with the secondary-structural elements of NMB2055 and CbnR shown. A grey line above the alignment indicates the residues that form the
putative effector pocket (Dundas et al., 2006). Sequence abbreviations: MC,N. meningitidis strain MC58; NGO,N. gonorrhoeae strain FA1090; Ecoli, E. coli strain K12; Salty,
S. typhimurium.
in S. typhimurium (directly or indirectly) by MetR include metA
(Mares et al., 1992) and glyA (Plamann & Stauffer, 1989), which are
also genes of methionine biosynthesis, and hmp (Poole, 2005). Hmp
encodes flavohaemoglobin, a nitric oxide (NO) detoxifying protein
(Membrillo-Herna´ndez et al., 1998; Stevanin et al., 2007). In E. coli,
MetR mediates the up-regulation of hmp in response to S-nitroso-
glutathione (GSNO), which is used as an NO releaser. Since GSNO
can react directly to form S-nitrosohomocysteine and thus deplete the
cellular homocysteine pool, it is believed that the MetR-mediated
regulation of hmp is also modulated by homocysteine. Significantly,
this work established that MetR has a role in the response of bacteria
to oxidative stress (Membrillo-Herna´ndez et al., 1998).
In Neisseria there are no evident homologues of metA or hmp and
only one predicted homocysteine transmethylase (NMB0944), which
shares 55% amino-acid sequence identity with MetE. However, the
predictedmetE gene is not co-located with NMB2055 in the neisserial
genome. Together, these differences between E. coli and S. typhi-
murium on the one hand and N. meningitidis on the other indicate
that the functions and hence the genes regulated by MetR-like
proteins from different organisms may have diversified significantly.
As part of a structural genomics effort to solve the structures and
understand the biological role of LTTRs in Neisseria, we determined
the structure of the regulatory domain of the MetR-like protein
NMB2055 from N. meningitidis. The crystal structure of the regula-
tory domain revealed that there is a disulfide bond between Cys103
and Cys106 located in the putative effector-binding site. The struc-
tural role of this disulfide has been investigated by generating C103S
and C106S mutations and the structures of the mutant and wild-type
proteins were compared.
2. Experimental methods and results
2.1. Cloning, expression and purification of NMB2055 and the
regulatory domain of NMB2055
Full-length NMB2055 (Gene ID 904026) and the C-terminal
regulatory domain (residues 90–309) of NMB2055 were amplified
from genomic DNA (N. meningitidis MC58) with forward primers
50-AAGTTCTGTTTCAGGGCCCGATGGATTCCATTATCGAATT-
GCGCC-30 (FL-MetR) and 50-AAGTTCTGTTTCAGGGCCCGA-
CGGAAGGAGAGGCGGGAGAG-30 (RD-MetR) and the common
reverse primer 50-ATGGTCTAGAAAGCTTTATCAGACCGGTT-
CCAGTTCGCTC-30. PCR products were cloned into the vector
pOPINB (Berrow et al., 2007) using In-Fusion (Clontech). The
constructs, which contained a 3C protease-cleavable N-terminal
hexahistidine purification tag (MGSSHHHHHHSSGLEVLFQ#GP;
the cleavage site is shown in bold), were tested for soluble expression
by semi-automated small-scale screening (Berrow et al., 2007).
Double cysteine-to-serine mutants (C103S/C106S) of both full-length
and the regulatory domain of NMB2055 were made using PCR
amplification of the vectors with primers that incorporate the desired
mutations followed by treatment with DpnI.
Selenomethionine-labelled and unlabelled proteins were produced
in E. coli strain B834 (DE3) using methods described previously
(Nichols et al., 2009). Briefly, cells were grown at 310 K to an OD600 nm
of 0.6. The temperature was reduced to 293 K and protein expression
was induced with 0.5 mM IPTG (isopropyl -d-1-thiogalacto-
pyranoside). The cells were harvested by centrifugation at 20 h post-
induction. The target proteins were purified from the cleared lysate
by nickel IMAC (immobilized-metal affinity chromatography)
followed by gel filtration using an A¨KTAxpress platform at 277 K
(GE Healthcare). The His tag was removed with rhinovirus 3C
protease (the vector was kindly donated by A. Geerlof, EMBL,
Hamburg) before crystallization. The cleaved proteins were passed
through an nickel–IMAC column to remove the His-tagged 3C
protease. 100% incorporation of selenomethionine was confirmed by
mass spectrometry (Sainsbury et al., 2008).
2.2. Crystallization and structure determination of the regulatory
domain of NMB2055
Selenomethionine-labelled protein was concentrated to
15.5 mg ml1 in 20 mM Tris pH 7.5, 200 mM NaCl, 1 mM TCEP.
Crystallization experiments were performed in nanodrops dispensed
by a Cartesian Technologies Microsys MIC4000 robot. The crystals
used for data collection were optimized from the original condition of
20%(w/v) polyethylene glycol 6000, 0.1M Tris pH 8.0, 0.2M calcium
chloride (condition No. 47 of PACT premier, Molecular Dimensions)
using the standard OPPF additive screen (crystal I) or three-row
(crystal II) optimization procedures described by Walter et al. (2005).
Data were collected from crystals (space group P21) on beamline
BM14 at the ESRF, Grenoble, France to 2.5 A˚ resolution at three
wavelengths for crystal I and at a single wavelength for crystal II.
Crystal I was flash-cooled in perfluoropolyether PFO-X125/03 oil
(Lancaster Synthesis) and crystal II in a cryosolution consisting of
25%(v/v) glycerol and 75%(v/v) reservoir solution. Initial phases for
the regulatory domain were obtained in a MAD experiment using the
data collected from crystal I. 11 of a possible 12 selenium sites were
identified with the SHELX program suite (Sheldrick, 2008). SOLVE/
RESOLVE (Terwilliger, 2004) were then used for refinement of the
selenium positions and phase improvement. The model was built
manually using Coot (Emsley & Cowtan, 2004) and refined with CNS
(Jones et al., 1991) using simulated annealing and positional refine-
ment with main-chain NCS restraints followed by individual isotropic
B-factor refinement. The partially refined model was subsequently
refined against the data from crystal II, which had a lower mosaic
spread (Table 1), with BUSTER (Blanc et al., 2004). The structure has
been deposited in the PDB under accession code 4ab5.
2.3. Crystallization and structure determination of the NMB2055
regulatory domain C103S/C106S mutant
Purified NMB2055 regulatory domain C103S/C106S mutant protein
was concentrated to 27 mg ml1 in 20 mM Tris pH 7.5, 200 mM NaCl.
Crystals used for structure determination of the C103S/C106S protein
grew directly from the original screening plate in 2M ammonium
sulfate, 2%(v/v) polyethylene glycol 400, 100 mM HEPES–Na pH 7.5
(condition No. 39 of Crystal Screen, Hampton Research). Diffraction
data were collected on beamline ID23.2 at the ESRF. A cryosolution
consisting of 25%(v/v) glycerol and 75%(v/v) reservoir solution was
added directly to the drop and the crystal was flash-cooled in liquid
nitrogen. The crystals belonged to space group H32 and the structure
was determined by molecular replacement with MOLREP using the
wild-type regulatory-domain dimer as the input model (Lebedev et
al., 2008). The model was refined to a resolution of 2.8 A˚ with
BUSTER (Blanc et al., 2004; Table 1). The structure has been
deposited in the PDB under accession code 4ab6.
3. Results
3.1. Overall structure of the regulatory domain of NMB2055
N-terminally hexahistidine-tagged versions of both full-length and
the regulatory domain of the N. meningitidis MetR-like protein
NMB2055 were purified by metal-affinity chromatography and size-
structural communications
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exclusion chromatography (SEC). The full-length protein, which has
a calculated molecular weight of 34.7 kDa, had an SEC retention time
corresponding to a molecular mass of 140 kDa. This indicated that
the protein behaves as a tetramer, which corresponds to the typical
oligomeric state of LTTRs (Muraoka et al., 2003; Monferrer et al.,
2010). The molecular mass of the regulatory domain was estimated to
be 35 kDa from size-exclusion analysis, compared with a calculated
molecular weight of 25 kDa. Therefore, no clear conclusion can be
drawn about the oligomeric state of the protein.
Following cleavage of the His tag, crystallization experiments were
set up with both the purified full-length protein and the regulatory
domain (residues 90–309). Diffracting crystals were only obtained
from the regulatory-domain construct and the structure was solved to
a resolution of 2.5 A˚ by the multiple-wavelength anomalous disper-
sion method using selenomethionine-substituted protein.
The crystal structure of the regulatory domain of NBM2055
contains a dimer in the asymmetric unit with the two chains of the
domain arranged in a head-to-tail orientation (Fig. 1), which is very
similar to the quarternary structure previously reported for other
regulatory domains of LTTRs (see, for example, Ezezika et al., 2007;
Devesse et al., 2011; Sainsbury et al., 2010). Each chain of the regu-
latory domain comprises two subdomains of similar size that each
adopt a Rossmann-like fold: RD-I (residues 92–166 and 270–307) and
RD-II (residues 167–269). Residues 90–91 and 308–309 of chain A
and residue 309 of chain B located at the N- or C-termini were
disordered. Superimposition of the two regulatory-domain mono-
mers showed an overall r.m.s.d. of 0.22 A˚ for 214 C atoms. The
predicted overall electrostatic surface potential indicates that the
regulatory domain of NMB2055 is largely acidic, which fits with its
predicted isoelectric point of 5.0.
3.2. The putative effector pocket of the NMB2055 regulatory
domain contains a disulfide bond
The regulatory-domain fold, in particular that of the first sub-
domain, is well conserved in LTTRs despite the low sequence identity
of the regulatory domains. However, an unexpected feature of the
RD-I subdomain of NMB2055 was the presence of a disulfide bridge
between Cys103 and Cys106 which covalently links the end of the first
-strand (1) to the start of 1 (Figs. 1a and 1b). The disulfide bridge
is located towards the base of a pocket at the interface of the RD-I
and RD-II subdomains which in other LTTRs is the binding site for
small-molecule effectors (Devesse et al., 2011; Ezezika et al., 2007;
Monferrer et al., 2010). The pocket in the neisserial structure has a
relatively large internal volume, with an average solvent-accessible
surface volume of 1043 A˚3, but a narrow entrance of 8  6 A˚
(Dundas et al., 2006). The area directly bordering the entrance to the
pocket is highly negatively charged. Cys103 is exposed to the solvent
with a solvent-accessible surface area of 42 A˚2, whereas Cys106 is
almost completely buried with a solvent-accessible surface area of
1 A˚2 (Krissinel & Henrick, 2007). The CHXC sequence (residues
103–106) and the proximal Trp109 in NMB2055 are highly conserved,
occurring in all 100 MetR homologues selected from the UniProt
database for conservation analysis (32–99% sequence identity using
ClustalW; Landau et al., 2005). This suggests that the motif is func-
tionally and/or structurally significant. 21 of the 35 residues that form
structural communications
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Table 1
Crystallographic statistics for the wild-type and C103S/C106S-mutant NMB2055 regulatory domains.
Values in parentheses are for the highest resolution shell.
SeMet wild type
Crystal I Crystal II C103S/C106S mutant
Data set Peak Remote Inflection Peak Native
Data collection
X-ray source BM14 BM14 ID23-EH2
Detector MAR 225 CCD MAR 225 CCD MAR 225 CCD
Space group P21 P21 H32
Unit-cell parameters
a (A˚) 60.9 65.2 136.9
b (A˚) 52.0 52.6 136.9
c (A˚) 63.4 65.9 127.8
 () 101.2 94.1 —
Wavelength (A˚) 0.9793 0.9078 0.9795 0.9790 0.8726
Resolution range (A˚) 30.0–2.50 (2.59–2.50) 30.0–2.70 (2.80–2.70) 30.0–2.70 (2.80–2.70) 30.0–2.50 (2.59–2.50) 50.0–2.80 (2.90–2.80)
Unique reflections 11655 (671) 10014 (601) 9953 (652) 13879 (826) 11470 (1128)
Completeness (%) 86.4 (50.0)† 93.2 (56.9)† 90.2 (59.4)† 89.8 (53.8)† 100 (100)
Multiplicity 9.9 (7.8) 3.7 (3.0) 3.4 (2.6) 6.4 (3.6) 18.1 (17.2)
Average I/(I) 34.5 (6.5) 17.0 (2.6) 17.9 (2.3) 19.6 (4.1) 21.4 (3.9)
Rmerge‡ 0.083 (0.234) 0.056 (0.223) 0.060 (0.264) 0.097 (0.214) 0.159 (0.865)
Refinement
Resolution (A˚) 30.0–2.50 43.4–2.80






R.m.s.d. bonds (A˚) 0.009 0.008
R.m.s.d. angles () 1.12 1.11
BWilson (A˚
2) 50.5 64.5













i IiðhklÞ. § Chen et al. (2010).
the putative effector pocket in the neisserial MetR homologue are
conserved in E. coli MetR, with many of the 14 amino-acid substi-
tutions being conservative changes (Fig. 1c). Most variations are
observed in residues 203–208 (3–3), which form part of the base of
the effector pocket, with a notable difference observed at residues
Glu203 and Met204 (Set197 and Arg198 in E. coli MetR), which are
located at the entrance to the pocket (Fig. 3a). The effector pocket of
NMB2055 has a mixed character; it is lined with the side chains of
several polar residues and a smaller number of nonpolar residues,
namely Glu102, Cys103, Cys106, His104, Thr105, Ser151, Tyr167,
Tyr198, Val200, Met204 and Leu205 (Fig. 3a, right panel).
The effector-binding pocket in the NMB2055 regulatory domain
was compared with the structure of the regulatory domain of BenM
bound to its inducer cis,cis-muconate. BenM regulates benzoate
metabolism inAcinetobacter baylyi and activates a cluster of four Ben
enzymes in response to the inducer (Ezezika et al., 2007). Of the
LTTR regulatory-domain structures available, BenM shows the
highest structural similarity to the NMB2055 protein using secondary-
structure matching (SSM; Krissinel, 2007). Comparison of the surface
representations of the BenM and NMB2055 proteins shows a marked
difference in the architecture of the effector-binding sites, with BenM
presenting an open cleft compared with the pocket with a narrow
entrance in the regulatory domain of NMB2055 (Fig. 2). However,
overlays of the muconate-bound BenM structure and the regulatory-
domain structure of NMB2055 shows that a comparably sized effector
could be accommodated in the NMB2055 pocket (Fig. 3a). A second
effector-binding site was identified in BenM, containing a benzoate
molecule. A similar secondary effector-binding site has also been
observed in the structure of the regulatory domain of DntR in
complex with salicylate (Devesse et al., 2011). Overlays show that the
corresponding position in NMB2055 is occluded by the side chains of
Trp109 and Phe165 (Fig. 3b).
3.3. Effects of C103S/C106S mutation on the structure of the
regulatory domain of NMB2055
To investigate the structural role of the conserved cysteines in
the putative effector pocket of NBM2055, single (C103S) and double
(C103S/C106S) point mutants were generated. No soluble protein
was obtained for the C103S mutant, presumably owing to the
presence of a free thiol at Cys106, whereas the C103S/C106S mutant
was purified and crystallized successfully. The C103S/C106S mutant
crystals diffracted to 2.8 A˚ resolution and belonged to a different
space group (H32) to the wild-type protein. A continuous model of
the mutant structure could be built, with the exception of disordered
residues that form part of the 2–2 loop (chain A, residue 131; chain
B, residues 131–134) and residues located at the N- or C-termini
(chain A, residues 90–93 and 309; chain B, residues 90–94 and 308–
309).
The regulatory domains of C103S/C106S-mutant and wild-type
NMB2055 superimposed with an overall r.m.s.d. (all C atoms) of
0.8 A˚, indicating that there is no large movement of the RD-I and
RD-II subdomains on removal of the disulfide bond between Cys103
and Cys106. However, there were significant local changes in the
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Figure 2
Comparison of the effector-bound structure of BenM (blue) with the regulatory-domain structure of NMB2055 (orange). ChainA of the regulatory domain of NMB2055 was
superimposed onto chain B of BenM (PDB entry 2f7a; Ezezika et al., 2007) with a core r.m.s.d. of 3.15 A˚ (196 residues). The effectors of BenM, cis,cis-muconate (primary
binding site) and benzonate (secondary binding site), are shown as yellow sticks. (a) Comparison of NMB2055 and effector-bound BenM. (b) Surface representation of the
BenM monomer and close-up of the primary effector-binding site. (c) Surface representation of the NMB2055 monomer and close-up of the putative primary effector-
binding site.
mutant structure centred around 2 (Figs. 4a and 4b). One of the
most apparent is a conformational change in the loop between the 1
and 1 elements that causes the side chain of Glu102 to point in
opposite directions in the two structures, extending towards the
3–4 loop in the C103S/C106S mutant and towards a different loop
(2–2) in the wild-type structure. In the wild-type structure of the
structural communications
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Figure 3
Comparison of the primary and secondary effector-binding sites of BenM (blue) and NMB2055 (orange). Superimposition of NMB2055 and BenM (PDB entry 2f7a) as in
Fig. 2. The effectors of BenM, cis,cis-muconate (muc) and benzonate (benz), are shown as yellow sticks. (a) Primary effector-binding site. (b) Secondary effector-binding site.
Figure 4
Effects of mutation of the Cys103 and Cys106 residues on the structure of the regulatory domain of NMB2055. Superimposition of the structures of the wild-type (coloured
blue through to red) and C103S/C106S double-mutant (grey) regulatory domain of NMB2055. (a) Comparison of wild-type and C103/C106-mutant structures. (b, c) Close-up
views of the primary effector pocket.
regulatory domain the terminal O atoms of the Glu102 side chain
(O"1 and O"2) are within hydrogen-bonding distance of the three
backbone N atoms of the Gly131, Phe132 and Gln133 residues of
the 2–2 loop. As the corresponding polypeptide is disordered in
the mutant structure one could reason that Glu102 has a role in
stabilizing the structure of the 2–2 loop in the wild-type protein. In
the C103S/C106S mutant Glu102 forms hydrogen bonds to the side
chain and backbone N atom of Ser151, which is part of the 3–4
loop and partially blocks the entrance to the putative effector pocket
(Fig. 4). The mutated Ser103 points towards the effector pocket, while
the position of Ser106 closely resembles the conformation of Cys106
in the wild-type protein (Fig. 4c). Associated with the above changes,
there appears to be a reduction in the overall size of the effector
pocket in the mutant, with an average solvent-accessible surface
volume of 516 A˚3 (compared with 1043 A˚3 for the wild type; Dundas
et al., 2006), although one limitation of this analysis is that it does not
include the disordered regions. The conformation of the residues of
the RD-II subdomain which form the base of the effector pocket
remains largely unchanged by the mutation (Fig. 4).
4. Discussion
On the basis of sequence homology, NMB2055 has been annotated
as a methionine regulator (MetR) and is representative of a large
homologous group of LysR-type transcription regulators (LTTRs).
The regulatory-domain structure of N. meningitidis reported here is
the first for this group of LTTRs. Generally, LTTRs respond to an
environmental cue through the binding of a small molecule to their
effector-binding pocket, which is located central to the two sub-
domains of the C-terminal regulatory domain (Ezezika et al., 2007).
Interactions between LTTRs and their co-activators appear to cause
a change in the relative positions of the N-terminal DNA-binding
domains, which in turn affects DNA binding and hence transcrip-
tional activity (Taylor et al., 2012). The NMB2055 structure clearly
shows a disulfide bond at the base of the putative effector pocket,
although it is unclear whether the formation of the disulfide bond
occurred within the E. coli cell or through air oxidation during
purification. Therefore, the oxidation state of the effector-pocket
cysteines has not been established. However, given the high level of
conservation of these residues amongst MetR-like LTTRs and their
location in the presumed effector-binding site, it is reasonable to
assume that the disulfide bridge plays a role in the function of MetR-
like transcription factors. While it remains unclear what this role
could be, there appears to be at least three possibilities.
(i) The disulfide bridge could provide a structural scaffold to the
effector pocket. The loss of the disulfide bond in the N. meningitidis
C103S/C106S-mutant protein clearly alters the structure around the
putative binding pocket as observed in the crystal structure.
(ii) The cysteines of the disulfide bond in MetR-like proteins could
play a role in redox sensing, as has been reported for a growing
number of transcriptional regulators, including the LTTR OxyR
(Choi et al., 2001), the global regulator Spx from Bacillus subtilis
(Nakano et al., 2003), the MerR family regulator AdhR from
B. subtilis (Nguyen et al., 2009) and the Mar family regulators OhrR
(Eiamphungporn et al., 2009) and YodB from B. subtilis (Leelak-
riangsak et al., 2008). Interestingly, Spx, which was first identified as
being necessary for the growth of B. subtilis during oxidative stress,
also contains a CXXCmotif which upon reaction with diamide can be
oxidized to a form an intramolecular disulfide bond. If the disulfide
bond is accessible and reversible (i.e. is capable of being reduced by
biologically relevant reducing agents such as reduced glutathione or
homocysteine) then this would in part indicate that it could have a
redox-sensing role. Whether homocysteine can bind in the effector
pocket remains unresolved. There is only circumstantial evidence for
direct binding of homocysteine to MetR proteins (Sperandio et al.,
2007) and we did not observe any electron density in cocrystallization
experiments which would correspond to homocysteine in the crystal
structure.
(iii) The cysteines could function to coordinate metal ions, which
is often the case for proteins containing CXXC motifs; for example,
zinc-finger proteins. Although no metal ions were detected in the
structure of the NMB2055 regulatory domain and the addition of
zinc to the buffer destabilized the protein to thermal denaturation
(thermal shift assay; unpublished data) this possibility cannot be
discounted.
The function of the MetR-like NMB2055 transcription factor in
Neisseria remains unknown and unfortunately its genetic locus does
not give any indication of what this might be since the divergent
gene (NMB2054) is annotated as hypothetical, although it is highly
conserved in Neisseria spp. However, the structural data reported
here provide the basis for rationally investigating the functional
consequences of site-specific modification of the protein.
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